Form 4: SOLESENCE Director Boosts Stake with Stock Purchases

SOLESENCE, INC. Director R. Janet Whitmore purchased 2,500 shares of common stock and updated her beneficial ownership, including deferred stock and options.

Summary

• R. Janet Whitmore, a Director of SOLESENCE, INC. (SLSN), acquired 2,500 shares of common stock on December 24, 2025.
• The purchases were made at prices of $1.91 for 1,500 shares and $1.9216 for 1,000 shares.
• These transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.
• Following these transactions, Ms. Whitmore's direct beneficial ownership of common stock increased to 2,086,698 shares.
• Ms. Whitmore also holds 20,030 shares of deferred common stock, which are payable upon her termination of service as a director under the Company's Non-Employee Director Deferred Compensation Plan.
• She holds various stock options, including 2,000 shares at $1.85 (expiring 11/17/2026), 20,000 shares at $4.17 (expiring 12/28/2028), 13,334 shares at $1.165 (expiring 12/20/2029), 12,600 shares at $0.61 (expiring 12/27/2030), and 12,000 shares at $2.44 (expiring 12/31/2031).
• The stock options generally vest in three equal annual installments starting on their respective exercisable dates.

Sentiment

Score: 7

Explanation: The director's purchase of company stock, especially under a 10b5-1 plan, is a positive indicator of insider confidence. While the amount is relatively small compared to total holdings, it still signals a belief in the company's value. No negative information was disclosed.

Positives

• A company director, R. Janet Whitmore, purchased 2,500 shares of common stock, indicating confidence in the company's future prospects.
• The purchases were made at prices of $1.91 and $1.9216, which could be seen as a positive signal if the current market price is higher or if the director believes the stock is undervalued.
• The transactions were executed under a Rule 10b5-1 plan, suggesting a pre-planned investment strategy rather than a reaction to immediate market events.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the vesting schedules and expiration dates of derivative securities.

Industry Context

This Form 4 filing, detailing insider buying, generally signals a director's belief in the company's future performance. In the broader industry context, insider purchases can be viewed positively by investors, suggesting that those with intimate knowledge of the company see value. However, without additional context on SOLESENCE, INC.'s specific industry or recent performance, it is difficult to draw further industry-specific conclusions.

Related Party Transactions

• The director's purchase of common stock constitutes a related party transaction, as it involves an insider (R. Janet Whitmore) acquiring securities from the company or on the open market while holding a position of influence.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence, potentially influencing investor sentiment.

Next Steps

• The deferred common stock becomes payable upon the reporting person's termination of service as a director.
• Stock options will vest in three equal annual installments beginning on their respective exercisable dates.

Key Dates

Recommendation

The director's purchase of shares is a positive signal of insider confidence, suggesting a belief in the company's value. However, the transaction volume is relatively small, and without additional financial context or company-specific news, it primarily serves as a confirmation of insider belief rather than a strong catalyst for a 'buy' recommendation. Investors should 'hold' and monitor for further developments or more comprehensive financial disclosures.

Keywords

SOLESENCE, INC., SLSN, Insider Buying, Form 4, Director Stock Purchase, Equity Acquisition, Stock Options, Deferred Stock, Rule 10b5-1